"Innocoll Technologies Ltd - Product Pipeline Analysis, 2013 Update" Is Now Available at Fast Market Research
Innocoll Technologies Ltd (Innocoll Technologies) is a biopharmaceutical company. The company develops and markets drug delivery devices for the pharmaceutical and medical markets. Its products include cogenzia, xaracoll, gentamicin surgical implant, procoll and durieva. The company's approved products include zorprevasurgical haemostat, collacare family, gentamicin surgical implant, collexa, lidocoll, collaguard adhesion barrier and innocoll dental. Its products are developed using its technologies namely CollaRx and Liquicoll. Innocoll Technologies products are used in a variety of medical applications such as preventing surgical...
View full press release